Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-12-12 Sale | 2025-12-15 5:24 pm | Xeris Biopharma Holdings Inc. | XERS | BORMANN-KENNEDY BARBARA-JEAN ANNE Director | 15,000 | $7.0943 | $106,415 | 142,500 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-06-04 Option Award | 2025-06-04 7:07 pm | N/A N/A | Xeris Biopharma Holdings Inc. | XERS | BORMANN-KENNEDY BARBARA-JEAN ANNE Director | 50,000 | $0 | 157,500 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-05 4:19 pm | N/A N/A | Xeris Biopharma Holdings Inc. | XERS | BORMANN-KENNEDY BARBARA-JEAN ANNE Director | 50,000 | $0 | 107,500 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-07 5:02 pm | N/A N/A | Xeris Biopharma Holdings Inc. | XERS | BORMANN-KENNEDY BARBARA-JEAN ANNE Director | 42,500 | $0 | 57,500 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-09 5:15 pm | N/A N/A | Xeris Biopharma Holdings Inc. | XERS | BORMANN-KENNEDY BARBARA-JEAN ANNE Director | 15,000 | $2.1 | 40,000 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-09 5:15 pm | 2022-06-08 2032-06-08 | Xeris Biopharma Holdings Inc. | XERS | BORMANN-KENNEDY BARBARA-JEAN ANNE Director | 25,000 | $0 | 40,000 (Direct) | View |
| 2021-10-05 Option Award | 2021-10-05 7:50 pm | N/A 2028-05-15 | Xeris Biopharma Holdings Inc. | XERS | BORMANN-KENNEDY BARBARA-JEAN ANNE Director | 62,106 | $0 | 62,106 (Direct) | View |
| 2021-06-08 Option Award | 2021-06-08 7:08 pm | N/A 2031-06-08 | XERIS PHARMACEUTICALS INC | XERS | BORMANN-KENNEDY BARBARA-JEAN ANNE Director | 11,228 | $0 | 11,228 (Direct) | View |